Back
11
Also listed as
ARHCF
OTC
Day Range
$16.01
$16.23
52-Week Range
$12.42
$16.39
Volume
58
50D / 200D Avg
$15.84
/
$15.54
Prev Close
$16.23
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 5.7 | 3.8 |
| Net Margin % | 0.9 | 3.9 |
| Rev Growth 5Y % | 3.3 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue grew 3.27% annually over 5 years — modest growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -10.87B
P/E of 0.11 — trading at a low valuation
Capital efficient — spends only 0.56% of revenue on capex
Growth
Revenue Growth (5Y)
3.27%
Revenue (1Y)3.59%
Earnings (1Y)-7.33%
FCF Growth (3Y)N/A
Quality
Return on Equity
5.70%
ROIC5.52%
Net Margin0.93%
Op. Margin1.29%
Safety
Debt / Equity
0.07
Current Ratio1.22
Interest Coverage136.49
Valuation
P/E Ratio
0.11
P/B Ratio0.01
EV/EBITDA-3.64
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.59% | Revenue Growth (3Y) | 4.80% |
| Earnings Growth (1Y) | -7.33% | Earnings Growth (3Y) | 3.06% |
| Revenue Growth (5Y) | 3.27% | Earnings Growth (5Y) | 2.83% |
| Profitability | |||
| Revenue (TTM) | 2.96T | Net Income (TTM) | 27.39B |
| ROE | 5.70% | ROA | 1.90% |
| Gross Margin | 7.22% | Operating Margin | 1.29% |
| Net Margin | 0.93% | Free Cash Flow (TTM) | -10.87B |
| ROIC | 5.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 1.22 |
| Interest Coverage | 136.49 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 0.11 | P/B Ratio | 0.01 |
| P/S Ratio | 0.00 | PEG Ratio | -3.19 |
| EV/EBITDA | -3.64 | Dividend Yield | 0.03% |
| Market Cap | 2.95B | Enterprise Value | -138.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.96T | 2.86T | 2.70T | 2.59T | 2.60T |
| Net Income | 27.39B | 29.56B | 25.79B | 32.18B | 24.50B |
| EPS (Diluted) | 147.54 | 154.13 | 127.42 | 153.57 | 115.75 |
| Gross Profit | 213.93B | 206.37B | 192.09B | 187.47B | 175.54B |
| Operating Income | 38.08B | 38.46B | 30.15B | 29.09B | 20.67B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.44T | 1.45T | 1.34T | 1.30T | 1.32T |
| Total Liabilities | 957.63B | 967.77B | 851.52B | 832.16B | 826.70B |
| Shareholders' Equity | 481.79B | 479.60B | 488.09B | 471.59B | 489.74B |
| Total Debt | 35.55B | 34.94B | 3.86B | 5.04B | 6.17B |
| Cash & Equivalents | 177.09B | 213.76B | 160.12B | 180.44B | 170.28B |
| Current Assets | 1.09T | 1.12T | 1.03T | 1.02T | 992.48B |
| Current Liabilities | 894.96B | 906.99B | 825.73B | 802.81B | 783.93B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#571 of 708
Recent Activity
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026